Skip to content
StockMarketAgent
Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

FRA/3L3 stock hub

FRA/3L3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/3L3is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
491.6M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/3L3FRA/3L3
Loading chart…
In the news

Latest news · FRA/3L3

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.6
P25 n/aP50 n/aP75 n/a
Trailing P/E27.9
P25 n/aP50 n/aP75 n/a
ROE9.6
P25 n/aP50 n/aP75 n/a
ROIC12.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/3L3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
197
Groups with data
11
Currency
USD
Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
1,086
Employees Change
45%
Employees Change Percent
4.54
Enterprise value
EUR 440.7M
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Electromedical and Electrotherapeutic Apparatus
Last refreshed
2026-05-10
Market cap
EUR 491.6M
Price
EUR 22.04
Price currency
EUR
Rev Per Employee
274,342.32x
Sic
3845
Symbol
fra/3L3
Website
https://tactilemedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
3.58%
EV Earnings
25.04x
EV/EBIT
16.07x
EV/EBITDA
12.22x
EV/FCF
12.95x
EV/Sales
1.51x
FCF yield
6.92%
Forward P/E
19.61x
P/B ratio
2.6x
P/E ratio
27.92x
P/S ratio
1.65x
PE Ratio10 Y
301.95x
PE Ratio3 Y
153.05x
PE Ratio5 Y
144.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
9.4%
EBITDA Margin
11.31%
FCF margin
11.42%
Gross margin
76.39%
Gross Profit
EUR 227.6M
Gross Profit Growth
20.04%
Gross Profit Growth Q
27.05%
Gross Profit Growth3 Y
12.65%
Gross Profit Growth5 Y
14.67%
Net Income
EUR 17.6M
Net Income Growth
25.33%
Pretax Margin
10.05%
Profit Margin
5.91%
Profit Per Employee
EUR 16,210
ROA
7.31
Roa5y
2.85
ROCE
13.67
ROE
9.59
Roe5y
2.3
ROIC
12.27
Roic5y
5.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

14
MetricValue
Cagr1y
157.95%
Cagr3y
10.58%
Cagr5y
-13.84%
EPS Growth
34.16
FCF Growth
3.63%
FCF Growth3 Y
86.76%
OCF Growth
4.75%
OCF Growth10 Y
35.74%
OCF Growth3 Y
74.51%
OCF Growth5 Y
107.82%
Revenue Growth
17.18x
Revenue Growth Q
22.85x
Revenue Growth3 Y
10.06x
Revenue Growth5 Y
13.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 1.24
Assets
EUR 236M
Cash
EUR 65M
Current Assets
EUR 129.6M
Current Liabilities
EUR 30.5M
Debt
EUR 13.2M
Debt EBITDA
EUR 0.36
Debt Equity
EUR 0.07
Debt FCF
EUR 0.39
Equity
EUR 189M
Interest Coverage
50.29
Liabilities
EUR 47.1M
Long Term Assets
EUR 106.4M
Long Term Liabilities
EUR 16.5M
Net Cash
EUR 51.9M
Net Cash By Market Cap
EUR 10.55
Net Cash Growth
49.65%
Net Debt EBITDA
EUR -1.54
Net Debt Equity
EUR -0.27
Net Debt FCF
EUR -1.52
Tangible Book Value
EUR 118M
Tangible Book Value Per Share
EUR 5.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.24
Inventory Turnover
4.58
Net Working Capital
EUR 39.1M
Quick ratio
3.57
Working Capital
EUR 101.3M
Working Capital Turnover
EUR 2.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
4.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
157.78%
200-day SMA
18.61
3Y total return
35.22%
50-day SMA
22.29
50-day SMA vs 200-day SMA
50over200
5Y total return
-52.5%
All Time High
65.91
All Time High Change
-66.56%
All Time High Date
2019-02-26
All Time Low
6.2
All Time Low Change
255.48%
All Time Low Date
2022-06-14
ATR
0.53
Ch YTD
-10.41
High
22.04
High52
28.8
High52 Date
2026-02-18
High52ch
-23.47%
Low
22.04
Low52
8
Low52 Date
2025-07-21
Low52ch
175.5%
Ma50ch
-1.13%
Price vs 200-day SMA
18.46%
RSI
56.58
RSI Monthly
58.72
RSI Weekly
54.52
Sharpe ratio
1.69x
Sortino ratio
3.88
Total Return
4.73%
Tr YTD
-10.41
Tr1m
4.75%
Tr1w
13.61%
Tr3m
-3.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
EUR 28M
Operating Income Growth
56.71
Operating Income Growth3 Y
43.85
Operating Income Growth5 Y
112.9
Operating margin
9.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
22,196,260%
Net Borrowing
-21,623,031
Shares Insiders
1.6%
Shares Institutions
91.97%
Shares Qo Q
-2.09%
Shares Yo Y
-4.73%
Short Ratio
4.63

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
EUR 27M
Average Volume
3.65x
Bv Per Share
8.32
CAPEX
EUR -2.4M
Ch1m
4.75
Ch1w
13.61
Ch1y
157.8
Ch3m
-3.33
Ch3y
35.22
Ch5y
-52.5
Ch6m
9.11
Change
3.09%
Change From Open
0
Close
21.38
Days Gap
3.09
Depreciation Amortization
5,559,238.9
Earnings Date
2026-05-04
EBIT
EUR 28M
EBITDA
EUR 33.7M
EPS
EUR 0.77
F Score
6
FCF
EUR 34M
FCF EV Yield
7.72x
Financing CF
-35,986,012
Fiscal Year End
December
Founded
1,995
Goodwill
33,540,288.9
Graham Number
12.26631
Graham Upside
-44.35
Income Tax
EUR 12.3M
Investing CF
-7,969,620
Is Primary Listing
0
Last Earnings Date
2026-05-04
Last Report Date
2026-03-31
Ma150
21.29
Ma150ch
3.54%
Ma20
20.68
Ma20ch
6.6%
Net CF
-7,481,330
Open
22.04
P FCF Ratio
14.45
P OCF Ratio
13.48
Ppne
15,692,384.8
Price Date
2026-05-08
Price EBITDA
EUR 14.59
Ptbv Ratio
4.17
Relative Volume
1.47x
Revenue
297,935,763x
SBC By Revenue
2.35x
Share Based Comp
6,999,978
Tax By Revenue
4.14x
Tax Rate
41.19%
Tr6m
9.11%
Volume
0
Z Score
7.06
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/3L3 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/3L3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+157.8%
S&P 500 1Y: n/a
3Y total return
+35.2%
S&P 500 3Y: n/a
5Y total return
-52.5%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/3L3?

Insider, institutional, and short-interest positioning.

Institutional ownership
+92.0%
Share of float held by funds and institutions
Insider ownership
+1.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
4.6 days to cover
Y/Y dilution
-4.7%
Negative means the company is buying back shares.
Technical

FRA/3L3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
56.6
Neutral momentum band
Price vs 200-day MA
+18.5%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.69
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/3L3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/3L3 stock rating?

fra/3L3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/3L3 analysis?

The full report lives at /stocks/fra/3L3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/3L3?

The latest report frames fra/3L3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/3L3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/3L3 stock profile: metrics, valuation and analysis | 주식시장 AI 에이전트